U.S. flag

An official website of the United States government

GTR Home > Tests > Variant Resolution Test for Penn Cancer Grant Panel (+RNAinsight®)

Laboratory contact

Laboratory information


Ambry Genetics

Laboratory director(s)

  • Elizabeth Chao, MD, Lab Director
  • Brigette Davis, PhD, ABMGG Board Certified, Diplomate of the American Board of Medica, Lab Director
  • Chia-Ling Gau, PhD, ABMGG Board Certified, Diplomate of the American Board of Medica, Lab Director

Laboratory contact for this test

  • Monalyn Salvador, MS, CGC, Manager, Product Management - Oncology
  • Phone Number: 949-457-8961
  • Email: mumali@ambrygen.com

Laboratory contact

  • 7 Argonaut
  • Aliso Viejo, California 92656
  • United States

Laboratory services offered

  • Carrier Screening
  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Confirmation of research findings
  • Insurance billing
  • Insurance preauthorization
  • Insurance preverification
  • Maternal cell contamination study (MCC)
  • Mutation Confirmation
  • Non-Invasive Prenatal Testing
  • Whole Exome Sequencing

Laboratory participation in external programs


Laboratory credentials

CLIA certification

  • Number: 05D0981414, Expiration: 2024-05-29

State license(s)

  • MD - Maryland Department of Health and Mental Hygiene DHMH, License number: 1052, Effective: 2018-07-01, Non-expiring
  • NY - New York State Department of Health NYSDOH, License number: PFI: 8160, Expiration: 2023-06-30
  • PA - Pennsylvania Department of Health PADOH, License number: 27832A, Expiration: 2023-08-15
  • CA - California Department of Public Health CDPH, License number: CDF00011694, Expiration: 2023-10-17
  • RI - State of Rhode Island Department of Health RIDOH, License number: LCO00680, Expiration: 2023-12-30


  • CAP, Number: 7154701, Expiration: 2024-10-26

Suggested reading

Practice guidelines

  • NCCN, 2023
    NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2023
  • ACMG ACT, 2019
    American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019
  • ACMG ACT, 2012
    American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012
  • EuroGenetest, 2011
    Clinical utility gene card for: familial adenomatous polyposis (FAP) and attenuated FAP (AFAP).

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.